Alembic Pharma receives US FDA approval for lamotrigine orally disintegrating tablets USP, 25 mg, 50 mg, 100 mg & 200 mg: Our Bureau, Mumbai Thursday, February 26, 2026, 14:15 Hrs ...

Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine ...

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine Orally Disintegrating Tablets USP, 25 mg, ...

Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Lamotrigine Orally Disintegrating ...

DETROIT, Nov. 12 -- Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) announced today that the US Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated ...

Lamotrigine 25mg, 50mg, 100mg, 200mg, 250mg, 300mg; ext-rel tabs. Swallow whole. Take once daily. Adjunctive therapy for primary generalized tonic-clonic and partial onset seizures: ≥13yrs: adding to ...

Lamotrigine (Lamepil (50 mg)) is an anticonvulsant agent, prescribed for epilepsy and bipolar disorder either alone or combined with other medications. In epilepsy it is used for partial seizures, ...

September 6, 2006 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for ciprofloxacin 200-mg/20-mL, 400-mg/40-mL, and 1200-mg/20-mL single-dose vials in the ...

Combining lamotrigine with quetiapine improves the treatment of depressive symptoms in patients with bipolar disorder, with the benefits maintained for at least a year, show findings from the CEQUEL ...